News
-
At the next IPAC-RS conference, March 29-31 in Rockville, MD, sponsored by the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS), OINDP specialists will have uncommon opportunities to interact with regulators, representatives of patient… Read more . . .
-
On Friday, December 10, just as the snow was beginning to melt in Edinburgh, DDL 21 concluded with one last podium session. Delegates also had a chance to spend some additional time at the exhibition.… Read more . . .
-
The second day of DDL 21 offered a wide variety of presentations, a focus on young investigators and the presentation of several awards, in addition to a continuation of the exhibition. By Day 2, most… Read more . . .
-
DDL 21 kicked off on Wednesday, December 8 with an EPAG workshop on the abbreviated impactor measurement (AIM) technique attended by 85 inhalation scientists who elected to attend the workshop in addition to the main… Read more . . .
-
Over the past few years, it has become increasingly difficult to ignore the rising cultural influence of social media. One of this year’s top movies documents the founding of Facebook; even major news outlets report… Read more . . .
-
David Cipolla, Aradigm A number of outstanding books have been written for medical practitioners who treat lung disease, including Murray and Nadel’s Textbook of Respiratory Medicine and Farzan’s Concise Handbook of Respiratory Diseases. These books… Read more . . .
-
Australian company Pharmaxis is launching its Aridol inhaled dry powder mannitol bronchial challenge test in the US. The FDA approved the product in October 2010 for the assessment of bronchial hyperresponsiveness in patients 6 years… Read more . . .
-
The Asthma and Allergy Foundation of America (AAFA) has published its annual list of US “asthma capitals,” led this year by Richmond, Virginia. The list ranks 100 metropolitan areas in terms of difficulties that they… Read more . . .
-
Submit abstracts online at www.omicsonline.org/BABE2011/abstract.php or email to BABE2011@omicsonline.org. See abstract submission tracks. Read more . . .
-
A dosage trial of Verona Pharma’s inhaled mixed phosphodiesterase (PDE) 3/4 inhibitor RPL554 for the treatment of mild asthma has demonstrated positive bronchodilation without any significant adverse effects at dosages two and four times higher… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden